MUSK and myasthenia gravis: Myasthenia gravis (MG) is a prototypical autoimmune disease characterized by autoantibodies against acetylcholine receptor (AChR), muscle-specific tyrosine kinase (MuSK) or other postsynaptic muscle-associated proteins, and immunosuppressive therapies (ISTs) are inevitable for managing MG [4].